Bioscript Group
Bioscript Group is a leading healthcare communications company specializing in medical communications, market access, regulatory writing, scientific storytelling, and innovative data insights. They focus on delivering high-quality, strategic, and digital solutions across the product lifecycle, with a strong emphasis on complex diseases, oncology, rare diseases, and personalized medicine. Their mission is to make complex diseases easier to navigate and to support clients in achieving commercial success and improved patient outcomes through integrated, creative communication services and data-driven insights.
Industries
Nr. of Employees
medium (51-250)
Bioscript Group
Products
Data insights and analytics platform
Platform-enabled analytics that use algorithmic and data-science methods to summarise conference abstracts, publications and real-world datasets to inform strategic communications, HEOR and therapeutic-area insight generation.
Data insights and analytics platform
Platform-enabled analytics that use algorithmic and data-science methods to summarise conference abstracts, publications and real-world datasets to inform strategic communications, HEOR and therapeutic-area insight generation.
Services
Development of structured communication platforms and plans that define core scientific statements, evidence pillars and a shared lexicon for consistent cross-functional messaging.
Creation and management of manuscripts, congress materials, posters, plain-language summaries and multi-channel medical communications for varied stakeholder audiences.
Authoring, review and QC of regulatory documents including clinical study reports, protocols and CTD modules, with senior-writer oversight and scalable resourcing.
Use of generative AI and ML to support literature review, draft generation and data synthesis for regulatory documents, delivered with human oversight and QC processes.
Development of value strategies, payer evidence plans, pricing and reimbursement approaches, and facilitation of payer research and advisory boards.
Platform-enabled algorithmic analysis of conference abstracts, publications and real-world datasets, plus social listening and bespoke data science support to inform communications and HEOR strategies.
Development of structured communication platforms and plans that define core scientific statements, evidence pillars and a shared lexicon for consistent cross-functional messaging.
Creation and management of manuscripts, congress materials, posters, plain-language summaries and multi-channel medical communications for varied stakeholder audiences.
Authoring, review and QC of regulatory documents including clinical study reports, protocols and CTD modules, with senior-writer oversight and scalable resourcing.
Use of generative AI and ML to support literature review, draft generation and data synthesis for regulatory documents, delivered with human oversight and QC processes.
Development of value strategies, payer evidence plans, pricing and reimbursement approaches, and facilitation of payer research and advisory boards.
Platform-enabled algorithmic analysis of conference abstracts, publications and real-world datasets, plus social listening and bespoke data science support to inform communications and HEOR strategies.
Expertise Areas
- Medical communications and scientific publication planning
- Regulatory writing and submission support
- Market access, HEOR and payer strategy
- Strategic product communication planning (SCPs)
Key Technologies
- Generative AI for document drafting and summarisation
- Machine learning for data analytics
- Natural language processing and social listening
- Real-world evidence analytics
News & Updates
Bioscript Group has announced the acquisitions of Fortis Pharma Consulting and Valid Insight, expanding its capabilities in medical affairs, market access, and strategic consulting.
The acquisition of Meridian HealthComms enhances Bioscript's medical communications, strategic planning, and creative services capabilities.
The acquisition of Enzyme Communications adds expertise in scientific storytelling, data-driven content, and complex disease communication.
An overview of recent insights into prostate cancer management, including new treatment strategies and evolving clinical practices.
A discussion on how data-driven insights are transforming medical decision-making and communication strategies.
Exploring how AI and human expertise are combined to improve regulatory medical writing processes.
Bioscript Group has announced the acquisitions of Fortis Pharma Consulting and Valid Insight, expanding its capabilities in medical affairs, market access, and strategic consulting.
The acquisition of Meridian HealthComms enhances Bioscript's medical communications, strategic planning, and creative services capabilities.
The acquisition of Enzyme Communications adds expertise in scientific storytelling, data-driven content, and complex disease communication.
An overview of recent insights into prostate cancer management, including new treatment strategies and evolving clinical practices.
A discussion on how data-driven insights are transforming medical decision-making and communication strategies.
Exploring how AI and human expertise are combined to improve regulatory medical writing processes.